Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets (Unaudited)

v3.24.1.1.u2
Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash $ 5,505,975 $ 6,989,424
Acquired patents, net 4,488 5,391
Total assets 5,510,463 6,994,815
Current liabilities    
Accounts payable & accrued interest 346,582 256,317
Unreimbursed expenses 43,029 38,089
Total current liabilities 389,611 294,406
Total liabilities 389,611 294,406
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,875,282 and 12,848,165 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 12,876 12,848
Additional paid-in capital 57,945,740 57,052,130
Accumulated deficit (52,837,764) (50,364,569)
Total stockholders’ equity 5,120,852 6,700,409
Total liabilities and stockholders’ equity $ 5,510,463 $ 6,994,815